(2,2-difluorocyclopropyl)acetic acid, 95.0%, 250mg

CYCLOPENTANECARBOXYLIC ACID, 2-OXO-, 1-METHYLETHYL ESTER, 95%, 100mg

Methyl 4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate>98.0%(HPLC)(T)5g

(2R,2'R,3S,3'S,4R,4'R,5R,5'R,6S,6'S)-6,6'-(([2,2'-bithiophene]-5,5'-diylbis(methylene))bis(4-methyl-3,1-phenylene))bis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol), 98%, 5mg

(S)-(2-Oxooxazolidin-4-yl)methyl 4-methylbenzenesulfonate, 98%, 100mg

N-(4-Aminobutyl)-N-ethylisoluminol, 95.0%, 500mg

Tetrakis(2-ethylhexyl) Orthosilicate>97.0%(GC)5mL

2-Phenylethyl n-Octanoate>98.0%(GC)25g

4-(2-Hydroxyethyl)morpholine>99.0%(GC)500mL

Boc-Met(O)-OH, 95%, 100g

Dialysis membrane Spectra/Por® 7 MWCO 10,000, 45 mm, 1 Piece(s)

7H-Dibenzo[c,g]carbazole, 95.0%, 5g

(2,6-Dimethylphenyl)methanol, 95.0%, 1g